The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utility of fluoro-deoxy-glucose positron emission tomography (FDG-PET) to predict a pelvic lymph node involvement (LNI) in patients (pts) with muscle-invasive bladder cancer (MIBC) enrolled in neoadjuvant therapy trials.
 
Antonio Cigliola
No Relationships to Disclose
 
Giuseppe Basile
No Relationships to Disclose
 
Chiara Mercinelli
No Relationships to Disclose
 
Daniele Raggi
No Relationships to Disclose
 
Valentina Tateo
No Relationships to Disclose
 
Damiano Alfio Patanè
No Relationships to Disclose
 
Emanuele Crupi
No Relationships to Disclose
 
Maurizio Colecchia
No Relationships to Disclose
 
Renzo Colombo
No Relationships to Disclose
 
Giulio Avesani
No Relationships to Disclose
 
Chiara Re
No Relationships to Disclose
 
Alberto Briganti
No Relationships to Disclose
 
Francesco Montorsi
No Relationships to Disclose
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Catalym; Clovis Oncology; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Gilead Sciences; Ipsen; Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Pfizer; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)